The Tennessee Board of Pharmacy said it has adopted new regulations for compounding pharmacies licensed by the state following recent outbreaks of illnesses associated with tainted medicines created at these specialty pharmacies.
The Pharmacy Board said in a news release that the new rules will improve safeguards for public health while also ensuring that drugs in short supply will be available. Compounding pharmacies mix custom formulations of drugs based on doctors’ specifications.
The board said the changes include expedited suspension of sterile compounding by a pharmacy or manufacturer after a serious problem is discovered and adding sterile compounding registration to licenses issued by the state.
Drug manufacturers doing business in Tennessee will also be required to show they are registered with the U.S. Food and Drug Administration.
Topics Legislation
Was this article valuable?
Here are more articles you may enjoy.
Alliant Latest to Sue Howden US Over Alleged ‘Smash-and-Grab’ Poaching 
Experian: AI Agents Could Overtake Human Error as Major Cause of Data Breaches 
SIAA Announces Strategic Partnership With Progressive 
Supreme Court Rejects Challenge to $2.46B Boy Scouts Sex Abuse Settlement 
